C
CLRB
Cellectar Biosciences Inc
2.760
-0.060-2.13%After Hours: 2.810 +0.050 +1.81%19:01 04/10 EDT
OPEN/PREV CLOSE2.730/2.820
TODAY RANGE2.670-2.910
VOL6.27K
MARKET CAP11.70M
52 WEEK RANGE2.430-20.59
AVG VOL (3M)64.29K
% TURNOVER0.15%
TURNOVER--
P/E (TTM)-0.3304
% RANGE7.80%
EPS(TTM)-8.3544
P/E(FORWARD)-0.6579
P/B1.180
BVPS2.339
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP11.25M
SHARES OUTSTANDING4.24M
NEXT EARNINGS05/11-05/15
FREE FLOAT4.07M
LOT SIZE1
EX-DATE06/24/2025
News
Press Releases
Financial Reports
Profile
NASDAQ·03/11 00:03
Maxim Group Upgrades Cellectar Biosciences (CLRB)
Dow Jones·03/10 13:29
Cellectar Biosciences Raised to Buy From Hold by Maxim Group
Dow Jones·03/10 13:29
Cellectar Biosciences Price Target Announced at $10.00/Share by Maxim Group
Benzinga·03/10 13:20
Maxim Group Upgrades Cellectar Biosciences to Buy, Announces $10 Price Target
Reuters·03/10 12:09
CELLECTAR BIOSCIENCES INC <CLRB.O>: MAXIM GROUP RAISES TO BUY FROM HOLD
TipRanks·03/10 11:45
Cellectar Biosciences upgraded to Buy from Hold at Maxim
Reuters·03/10 07:23
U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, FedEx
TipRanks·03/10 00:16
Cellectar Biosciences Charts Risky Path to Approvals
TipRanks·03/04 14:50
Cellectar Biosciences price target lowered to $14 from $18 at Roth Capital
Benzinga·03/04 12:18
Cellectar Biosciences Q4 EPS $(0.53) Beats $(2.29) Estimate
TipRanks·03/04 12:16
Cellectar Biosciences reports FY25 EPS ($8.35) vs ($41.89) last year
Seeking Alpha·03/04 12:16
Cellectar Biosciences GAAP EPS of -$8.35
Dow Jones·03/04 12:16
*Cellectar Biosciences 2025 Loss/Shr $8.35 >CLRB
Dow Jones·03/04 12:16
*Cellectar Biosciences 2025 Research and Development Expenses $11.5M >CLRB